C57BL/6-Gt(ROSA)26Sortm1.1(EGFP-DTA)Bcgen Rlbp1tm1(icre/ERT2-tdTomato)Bcgen/Bcgen • 115288
| Product name | B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice |
|---|---|
| Catalog number | 115288 |
| Strain name | C57BL/6-Gt(ROSA)26Sortm1.1(EGFP-DTA)Bcgen Rlbp1tm1(icre/ERT2-tdTomato)Bcgen/Bcgen |
| Strain background | C57BL/6 |
| NCBI gene ID | (Mouse) |
| Aliases | CRALBP; 3110056M11Rik |
Gene targeting strategy for B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice.
An icre/ERT2-tdtomato sequence cassette was placed in the mouse Rlbp1 gene under the control of the Rlbp1 promoter in B-Rlbp1-iCreERT2-tdtomato mice.
B-ROSA26-EGFP-DTA mice have STOP cassettes preventing expression of diphtheria toxin fragment A (DTA). DTA expression will be activated, if STOP cassettes are removed, resulting in the specific ablation of the cre-expressing cells. ROSA26-EGFP-DTA mice are useful for Cre-inducible deletion of specific groups of cells.
B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice were obtained by crossing B-Rlbp1-iCreERT2-tdtomato mice (113974) and B-ROSA26-EGFP-DTA mice (110156).
TdTomato Expression in B-Rlbp1-iCreERT2-tdtomato mice. TdTomato expression was observed exclusively in the eye, confirming tissue-specific expression driven by the Rlbp1 promoter in B-Rlbp1-iCreERT2-tdtomato mice. Scale, 40x.
Tamoxifen-Induced retinal degeneration in B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice.
B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice (female, 6-week-old) were divided into two groups. G1 (n=2) received daily intraperitoneal (i.p.) vehicle injections for 5 days. G2 (n=3) received i.p. tamoxifen (1 mg/mouse) daily for 5 days. After a 7-day washout period, tissues were collected for and analyzed with H&E staining. The results showed that tamoxifen-induced ablation led to structural disruption across the retinal layers, cells in the GCL, INL, and ONL appeared disordered in B-EGFP-DTA, Rlbp1-iCreERT2-tdTomato mice. Scale, 200x.